The objective of this study was to determine the effect of macrophages on growth of human colon cancer cells. The results showed that co-culture of colon cancer cells with macrophages inhibited the growth of colon cancer cells (HCT116 and SW620) depending on the number of macrophages, RAW 264.7 cells, and activated THP-1 cells accompanied by down regulation of pSTAT3 in cancer cells. We also found that expression and release of cancer cell growth inhibitory cytokines, IL-1 receptor antagonist (IL-1ra) and IL-10, was increased in macrophages. Blocking of the STAT3 pathway with specific inhibitor and siRNA of STAT3 abolished the growth of colon cancer cells and expression of IL-1ra and IL-10. In addition, neutralization of IL-1ra and IL-10 with antibodies resulted in reversal of macrophage-induced inhibition of cancer cell growth. These data showed that IL-1ra and IL-10 released from macrophages inhibit growth of colon cancer cells through inhibition of the STAT3 pathway.

A new soybean cultivar for soy-paste, “Mansu”, was developed from the cross between ‘Suwon 192’, which was tolerant to disease, late maturing and high yielding, and ‘Suwon 196’ which was early maturing and large seed by soybean breeding team in the Yeongnam Agricultural Research Institute (YARI) to make new variety having large seed and high yielding. A promising line, SS97213-2B-3SSD-39-1-1, was selected and designated as the name of ‘Suwon 236’. It was characterized by regional yield trials (RYT) for three years from 2004 to 2006 and released as the name of “Mansu”. It has a determinate growth habit, purple flower, grey pubescence, pale green seed coat, yellow cotyledon, large spherical seed (26.5 grams per 100 seeds). Maturity date is 4 days later than the check cultivar, Taekwang. The average yield of Mansu was 2.93 ton per hectare in the regional yield trials (RYT) carried out for three years from 2004 to 2006 which was 7 percent higher than that of the check cultivar, Taekwang.